STSC - Start Scientific, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
-
-
-
-
Selling General and Administrative
71
10
3
1,308
Total Operating Expenses
71
10
3
1,308
Operating Income or Loss
-71
-10
-3
-1,308
Interest Expense
81
77
144
448
Total Other Income/Expenses Net
-46
78
-185
-166
Income Before Tax
-197
-8
-331
-1,921
Income Tax Expense
0
0
0
-
Income from Continuing Operations
-197
-8
-331
-1,921
Net Income
-197
-8
-331
-1,921
Net Income available to common shareholders
-197
-8
-331
-1,921
Reported EPS
Basic
-
-0.03
-1.34
-20.00
Diluted
-
-0.03
-1.34
-20.00
Weighted average shares outstanding
Basic
-
264
248
82
Diluted
-
264
248
82
EBITDA
-
68
-188
-1,473